Bristol-Myers Squibb Co (BMY)
54.32
-1.45
(-2.60%)
USD |
NYSE |
Nov 01, 16:00
54.66
+0.34
(+0.63%)
After-Hours: 20:00
Bristol-Myers Squibb Price to Book Value: 6.427 for Nov. 1, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 6.427 |
| October 31, 2024 | 6.598 |
| October 30, 2024 | 6.230 |
| October 29, 2024 | 6.212 |
| October 28, 2024 | 6.228 |
| October 25, 2024 | 6.143 |
| October 24, 2024 | 6.261 |
| October 23, 2024 | 6.278 |
| October 22, 2024 | 6.243 |
| October 21, 2024 | 6.167 |
| October 18, 2024 | 6.298 |
| October 17, 2024 | 6.293 |
| October 16, 2024 | 6.315 |
| October 15, 2024 | 6.243 |
| October 14, 2024 | 6.232 |
| October 11, 2024 | 6.177 |
| October 10, 2024 | 6.200 |
| October 09, 2024 | 6.248 |
| October 08, 2024 | 6.210 |
| October 07, 2024 | 6.324 |
| October 04, 2024 | 6.385 |
| October 03, 2024 | 6.413 |
| October 02, 2024 | 6.361 |
| October 01, 2024 | 6.260 |
| September 30, 2024 | 6.122 |
| Date | Value |
|---|---|
| September 27, 2024 | 6.066 |
| September 26, 2024 | 5.972 |
| September 25, 2024 | 5.952 |
| September 24, 2024 | 6.070 |
| September 23, 2024 | 5.959 |
| September 20, 2024 | 5.887 |
| September 19, 2024 | 5.841 |
| September 18, 2024 | 5.927 |
| September 17, 2024 | 5.897 |
| September 16, 2024 | 5.956 |
| September 13, 2024 | 5.854 |
| September 12, 2024 | 5.748 |
| September 11, 2024 | 5.790 |
| September 10, 2024 | 5.872 |
| September 09, 2024 | 5.779 |
| September 06, 2024 | 5.803 |
| September 05, 2024 | 5.934 |
| September 04, 2024 | 5.953 |
| September 03, 2024 | 6.020 |
| August 30, 2024 | 5.952 |
| August 29, 2024 | 5.924 |
| August 28, 2024 | 5.846 |
| August 27, 2024 | 5.734 |
| August 26, 2024 | 5.748 |
| August 23, 2024 | 5.732 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.034
Minimum
Mar 23 2020
8.520
Maximum
Dec 27 2019
4.154
Average
3.997
Median
Price to Book Value Benchmarks
| Amgen Inc | 22.80 |
| Johnson & Johnson | 5.495 |
| Eli Lilly and Co | 54.59 |
| Merck & Co Inc | 5.926 |
| Pfizer Inc | 1.815 |
Price to Book Value Related Metrics
| PS Ratio | 2.324 |
| Price to Free Cash Flow | 7.985 |
| Price | 54.32 |
| Earnings Yield | -6.61% |
| Market Cap | 110.17B |
| Operating PE Ratio | 15.14 |
| Normalized PE Ratio | 34.03 |